Krüppel-like factor 2 suppresses human gastric tumorigenesis through inhibiting PTEN/AKT signaling

Chunmei Wang1,2,3, Liang Li1, Qiuhui Duan1

  • 1East China Normal University and Shanghai Fengxian District Central Hospital Joint Center for Translational Medicine, Shanghai 200241, China.

Oncotarget
|December 17, 2017
PubMed

Insights

Krüppel-like factor 2 (KLF2) is downregulated in gastric tumors, suppressing cancer growth and progression. KLF2 inhibits gastric tumorigenesis by regulating the PTEN/AKT signaling pathway, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Krüppel-like factors (KLFs) are transcriptional regulators involved in cellular processes and cancer.
  • KLF2 is frequently dysregulated in various tumors, but its role in gastric cancer is unclear.

Purpose of the Study:

  • To investigate the role of KLF2 in human gastric tumorigenesis.
  • To elucidate the underlying molecular mechanisms of KLF2's function in gastric cancer.

Main Methods:

  • Analysis of KLF2 protein expression in gastric tumors and adjacent normal tissues.
  • In vitro cell experiments (proliferation, migration, invasion, apoptosis, cell cycle) with KLF2 manipulation.
  • In vivo xenograft tumor models to assess KLF2's effect on tumor growth.
  • Investigation of PTEN/AKT signaling pathway involvement and validation using specific inhibitors (AZD5363) and growth factors (IGF-1).

Main Results:

  • KLF2 protein expression was significantly lower in gastric tumors compared to normal tissues.
  • Downregulated KLF2 correlated with poorer patient survival.
  • Ectopic KLF2 expression suppressed gastric cancer cell proliferation, migration, and invasion, while enhancing apoptosis and inducing cell cycle arrest.
  • KLF2 deficiency promoted tumor growth in vitro and in vivo.
  • KLF2 regulated PTEN expression, impacting the PTEN/AKT signaling pathway.

Conclusions:

  • KLF2 acts as a tumor suppressor in human gastric cancer.
  • KLF2 suppresses gastric tumorigenesis by inhibiting the PTEN/AKT signaling axis.
  • KLF2 represents a potential therapeutic target for gastric cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K